MedTrace Logo

Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

NCT04065880 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2023-05-15

No results posted yet for this study

Summary

Postoperative prolonged air leak (PAL), referring to the passage of air from the lung parenchyma into the pleural space, is one of the most frequent postoperative complications after lung resection. To control air leak, there are two different products certified since years: TachoSil® and Neoveil®. This study is to investigate the difference of TachoSil® and Neoveil® in patients with PAL.

Conditions

  • Prolonged Air Leak
  • Postoperative Air Leak

Interventions

OTHER

TachoSil®

topical absorbable fibrin sealant patch applied directly on the lung area with air fistula.

OTHER

Neoveil®

bioabsorbable soft-tissue reinforcement material applied on the normal shape of the lung at the end of the operation.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Didier Lardinois, Prof. MD · Department of Thoracic Surgery, University Hospital Basel

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2021-07-01
Completion
2021-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04065880 on ClinicalTrials.gov